![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Deisenhammer Florian
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.23, Iss.5, 2009-05, pp. : 379-396
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Farrell Rachel Bendtzen Klaus Bertolotto Antonio Clark Berwyn Comabella Manuel Deisenhammer Florian Fogdell-Hahn Anna Giovannoni Gavin Hartung Hans Peter Hemmer Bernard Hillert Jan Kappos Ludwig Killestein Joep Lindberg Raija Montalban Xavier Polman Chris Sorensen Per Soelberg Goodin DS Hurwitz B Noronha A
The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis
CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Interferon-β1b in the treatment of multiple sclerosis
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. :